Study of VC004 for pain from bone metastases
Part of Bones, joints & muscles, Cancer, Pain clinical trials.
This trial tests an experimental pain medicine (VC004) for people with cancer that has spread to the bones and causes pain. It compares the study drug to a placebo (a dummy pill) to see if it helps with pain and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have pain from cancer that has spread to your bones.
- You are able to take care of yourself (like walking and doing daily tasks) with some help from time to time.
- You are expected to live at least 12 more weeks.
- You can follow the study schedule and talk with the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called VC004 for people with advanced solid tumors that have spread. It aims to see if the drug can shrink tumors or slow their growth.
This trial tests adding a bone-cement procedure (vertebroplasty) along with radiation to reduce pain from cancer that has spread to the spine. It is for adults with painful metastatic (spread) tumors in the middle or lower spine, without current spinal cord pressure.
This trial uses controlled, short-term pain testing (a “pain study”) to better understand how pain works during and after certain cancer treatments. It may help researchers improve how cancer therapy pain is measured and managed.
This trial tests a new injection called sss40 to treat moderate-to-severe pain caused by cancer that has spread to the bones. The goal is to see if it is safe and effective for people whose pain is not being controlled by current treatments.
This trial compares two types of radiation therapy—standard palliative radiation and a more targeted high-dose treatment (SBRT)—to see which better relieves pain from bone metastases that have spread outside the spine. It is for people with solid tumors who have a painful bone spot and are expected to live at least 6 months.
This Phase 2 study tests a new medicine (3D1002) taken together with extended-release oxycodone to improve moderate to severe cancer pain. You may be considered if your cancer pain is stable and you can follow the study’s strict pain-medication rules.
Hear when a new Pain in Bone Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.